Relationship Between Neutrophil Count and 90-Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial.

The CHANCE‐3 (Colchicine in High‐Risk Patients With Acute Minor‐to‐Moderate Ischemic Stroke or Transient Ischemic Attack) study tried to address the residual risk of stroke with the low dose of colchicine based on C‐reactive protein as an inclusion, but the results did not reach statistical significance. 7 Therefore, the specific mechanisms by which inflammation affects early stroke recurrence remain unclear.

also in 111,027 other papers